~ Targeted collaboration agreement will help further accelerate access to minimally invasive robotic surgery in select European and South American markets
~ CMR is delivering on its commercial strategy of rapid global expansion with systems installed across the world and more than 5,000 clinical cases performed
CMR Surgical (CMR) – the global surgical robotics business – today announces a collaboration agreement with Ethicon*, a Johnson & Johnson MedTech company**, to expand choice across surgical robotics and advanced laparoscopic instruments.
CMR’s Versius® system represents the next generation of collaborative surgical robotics as well as an industry leading clinical registry and comprehensive digital ecosystem that are complementary to Ethicon’s surgical technologies. As a global leader in MedTech, Ethicon specialises in best-in-class, clinically-differentiated surgical technologies and brings a suite of digital products and solutions that provide insights and education for surgeons.
The targeted collaboration agreement will focus on select private hospitals in Italy, France, Germany, and Brazil and will enable Ethicon and CMR commercial teams to offer specific hospitals the advantages of their complementary portfolios together. This streamlines and simplifies the process for surgeons to acquire these leading tools for the full range of patient surgery needs. It will increase choice and access to a broad portfolio of robotic and laparoscopic surgery solutions.
Versius is the only small, modular and portable robot on the market and is suitable for all sizes of hospitals and surgical care centres. The system allows surgeons the versatility to perform fully robotic as well as a combination of robotic and manual laparoscopic procedures, giving them freedom to decide how to provide patients with the best possible surgical care.
The agreement with Ethicon aligns with CMR’s commercialisation strategy of rapid global expansion, as it continues to provide hospitals with Versius Surgical Robotic Systems across key geographies. CMR will continue to work and collaborate independently, promoting and selling Versius directly to customers in these markets. The announcement follows the recent news that more than 100 Versius systems have now been installed worldwide.
CMR will continue to invest heavily in the high-quality training and servicing that is offered to customers adopting Versius, reinforcing the importance of education in the introduction of a new surgical robotics programme. By bringing together state of the art technology, education and servicing it will be possible to deliver even greater benefits for surgeons and patients.
Per Vegard Nerseth, Chief Executive Officer of CMR Surgical, comments: “Each patient’s surgery has distinct requirements to ensure that an optimal outcome is achieved. By entering into this collaboration agreement with Ethicon in select markets, CMR believes that this combination of expertise in minimal access surgery and digital innovation will deliver an optimised offering to customers. CMR looks forward to progressing this agreement in strategically important regions as CMR continues to rapidly expand on a global scale.”
*Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, LLC and certain of their affiliates. All other trademarks are the property of their respective owners.
**Johnson & Johnson MedTech comprise the surgery, orthopedics, vision and interventional solutions businesses within Johnson & Johnson’s MedTech segment.
ENDS
The Versius® Surgical Robotic System
Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.
Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.
But it’s more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.
About CMR Surgical Limited
CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot.
Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.
Founded in 2014, CMR Surgical is private limited company backed by an international shareholder base.
Supporting documents
Downloadable images
